BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 34398171)

  • 1. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
    Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
    JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study.
    Chan AYL; Gao L; Howard LM; Simonoff E; Coghill D; Ip P; Lau WCY; Taxis K; Wong ICK; Man KKC
    Psychother Psychosom; 2023; 92(2):113-123. PubMed ID: 36907183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study.
    Ge GM; Cheung ECL; Man KKC; Ip P; Leung WC; Li GHY; Kung AWC; Cheung CL; Wong ICK
    BMC Med; 2022 Nov; 20(1):390. PubMed ID: 36344981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
    Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
    JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders.
    Chen VC; Wu SI; Lin CF; Lu ML; Chen YL; Stewart R
    JAMA Netw Open; 2022 Nov; 5(11):e2243282. PubMed ID: 36413366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Gestational Age at Birth With Symptoms of Attention-Deficit/Hyperactivity Disorder in Children.
    Ask H; Gustavson K; Ystrom E; Havdahl KA; Tesli M; Askeland RB; Reichborn-Kjennerud T
    JAMA Pediatr; 2018 Aug; 172(8):749-756. PubMed ID: 29946656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between prenatal antipsychotic exposure and the risk of attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis.
    Wang Z; Yuen AS; Wong KH; Chan AY; Coghill D; Simonoff E; Lau WC; Wong IC; Park S; Man KK
    Neurosci Biobehav Rev; 2024 May; 160():105635. PubMed ID: 38499117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Antidepressants be Avoided in Pregnancy?
    Besag FMC; Vasey MJ
    Drug Saf; 2023 Jan; 46(1):1-17. PubMed ID: 36538238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures.
    Leppert B; Havdahl A; Riglin L; Jones HJ; Zheng J; Davey Smith G; Tilling K; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2019 Aug; 76(8):834-842. PubMed ID: 31042271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cord blood lipid correlation network profiles are associated with subsequent attention-deficit/hyperactivity disorder and autism spectrum disorder symptoms at 2 years: a prospective birth cohort study.
    Vacy K; Thomson S; Moore A; Eisner A; Tanner S; Pham C; Saffery R; Mansell T; Burgner D; Collier F; Vuillermin P; O'Hely M; Boon WC; Meikle P; Burugupalli S; Ponsonby AL;
    EBioMedicine; 2024 Feb; 100():104949. PubMed ID: 38199043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan.
    Meng LC; Lin CW; Lin YC; Huang ST; Chen YY; Shang CY; Wu CY; Chen LK; Chan KA; Hsiao FY
    Lancet Psychiatry; 2023 Jul; 10(7):499-508. PubMed ID: 37353262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and Other Neurodevelopmental Outcomes Associated With Antipsychotic Drug Exposure During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2022 May; 83(3):. PubMed ID: 35649168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood.
    Sundbakk LM; Gran JM; Wood ME; Handal M; Skurtveit S; Nordeng H
    JAMA Netw Open; 2022 Dec; 5(12):e2246889. PubMed ID: 36520439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm birth and small for gestational age potentiate the association between maternal hypertensive pregnancy and childhood autism spectrum disorder.
    Wang LW; Lin HC; Tsai ML; Chang YT; Chang YC
    Sci Rep; 2023 Jun; 13(1):9606. PubMed ID: 37311942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium.
    Kurth L; O'Shea TM; Burd I; Dunlop AL; Croen L; Wilkening G; Hsu TJ; Ehrhardt S; Palanisamy A; McGrath M; Churchill ML; Weinberger D; Grados M; Dabelea D
    J Neurodev Disord; 2024 May; 16(1):26. PubMed ID: 38796448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts.
    Alemany S; Avella-García C; Liew Z; García-Esteban R; Inoue K; Cadman T; López-Vicente M; González L; Riaño Galán I; Andiarena A; Casas M; Margetaki K; Strandberg-Larsen K; Lawlor DA; El Marroun H; Tiemeier H; Iñiguez C; Tardón A; Santa-Marina L; Júlvez J; Porta D; Chatzi L; Sunyer J
    Eur J Epidemiol; 2021 Oct; 36(10):993-1004. PubMed ID: 34046850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability.
    Ahlqvist VH; Sjöqvist H; Dalman C; Karlsson H; Stephansson O; Johansson S; Magnusson C; Gardner RM; Lee BK
    JAMA; 2024 Apr; 331(14):1205-1214. PubMed ID: 38592388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa).
    Havdahl A; Wootton RE; Leppert B; Riglin L; Ask H; Tesli M; Bugge Askeland R; Hannigan LJ; Corfield E; Øyen AS; Andreassen OA; Tilling K; Davey Smith G; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2022 Aug; 79(8):799-810. PubMed ID: 35793100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of attention-deficit/hyperactivity disorder and autism in 12-year-old children: A population-based cohort.
    Fast K; Wentz E; Roswall J; Strandberg M; Bergman S; Dahlgren J
    Dev Med Child Neurol; 2024 Apr; 66(4):493-500. PubMed ID: 37740541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
    Harris GM; Wood M; Ystrom E; Nordeng H
    JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.